Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Kuros Biosciences AG (SW: KURN)

 
KURN Technical Analysis
5
As on 2nd Apr 2025 KURN STOCK Price closed @ 19.22 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 7.80 & Strong Buy for SHORT-TERM with Stoploss of 3.49 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

KURNSTOCK Price

Open 19.00 Change Price %
High 19.42 1 Day -0.16 -0.83
Low 18.64 1 Week 0.52 2.78
Close 19.22 1 Month -4.48 -18.90
Volume 106644 1 Year 16.55 619.85
52 Week High 31.25 | 52 Week Low 2.44
 
SW Switzerland Most Active Stocks
CSGN 0.82 0.00%
CSGN 0.82 0.00%
UBSG 26.78 -0.07%
UBSG 26.78 -0.07%
NESN 89.80 -0.40%
NESN 89.80 -0.40%
NOVN 96.82 -1.63%
NOVN 96.82 -1.63%
ARYN 1.97 -0.51%
ARYN 1.97 -0.51%
 
SW Switzerland Top Gainers Stocks
CADN 0.03 50.00%
PRFN 0.03 50.00%
PRFN 0.03 50.00%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
CASN 1.90 8.57%
SKIN 32.50 8.33%
SKIN 32.50 8.33%
 
SW Switzerland Top Losers Stocks
HLEE 6.00 -23.57%
RLF 2.04 -12.82%
RLF 2.04 -12.82%
RLF 2.04 -12.82%
RLF 2.04 -12.82%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
 
 
KURN
Daily Charts		 KURN
Intraday Charts		 Whats New @
Bazaartrend		 KURN
Free Analysis
 
KURN Important Levels Intraday
RESISTANCE20.72
RESISTANCE20.24
RESISTANCE19.94
RESISTANCE19.65
SUPPORT18.79
SUPPORT18.50
SUPPORT18.20
SUPPORT17.72
 
KURN Forecast April 2025
Share
4th UP Forecast22.59
3rd UP Forecast21.51
2nd UP Forecast20.84
1st UP Forecast20.17
1st DOWN Forecast18.27
2nd DOWN Forecast17.6
3rd DOWN Forecast16.93
4th DOWN Forecast15.85
 
KURN Weekly Forecast
4th UP Forecast19.86
3rd UP Forecast19.65
2nd UP Forecast19.53
1st UP Forecast19.40
1st DOWN Forecast19.04
2nd DOWN Forecast18.91
3rd DOWN Forecast18.79
4th DOWN Forecast18.58
 
KURN Forecast2025
4th UP Forecast76.36
3rd UP Forecast58.03
2nd UP Forecast46.71
1st UP Forecast35.38
1st DOWN Forecast3.06
2nd DOWN Forecast-8.27
3rd DOWN Forecast-19.59
4th DOWN Forecast-37.92
 
 
KURN Other Details
Segment EQ
Market Capital 72147024.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
KURN Address
KURN
 
KURN Latest News
 
Your Comments and Response on Kuros Biosciences AG
 
KURN Business Profile
Kuros Biosciences AG, a biopharmaceutical company, engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases in the United States, the United Kingdom, and internationally. Its sealants pipeline products include Neuroseal EU and US for the treatment of dural sealant cranial. The company's orthobiologics pipeline products include MagnetOs Granules and MagnetOs Putty in EU and US for the treatment of orthopedics, spinal, and dental problems. Its fibrin/PTH orthobiologics pipeline products comprise KUR-111, which has completed Phase II clinical trial for the treatment of tibial plateau fractures; and KUR-113, which completed Phase II clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase I trial for the treatment of spinal interbody fusion. The company has collaboration with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. Kuros Biosciences AG is headquartered in Schlieren, Switzerland. Address: Wagistrasse 25, Schlieren, Switzerland, 8952
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service